Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (461-470 of 504) with videos related to

Pageof 51
Sort By:
Gut|September 15, 2022
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinomaMónica P de Andrés, Richard J Jackson, Irene Felipe, et al.
The Lancet Regional Health. Europe|November 30, 2023
Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysisAnika Kästner, Anna Kron, Neeltje van den Berg, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Ebiomedicine|February 6, 2023
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseasesAlexander M Bernhardt, Steffen Tiedt, Daniel Teupser, et al.
Virchows Archiv : an International Journal of Pathology|November 25, 2019
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
Pageof 51

Showing results (461-470 of 504) with videos related to

Sort By:
Pageof 51
Gut|September 15, 2022
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinomaMónica P de Andrés, Richard J Jackson, Irene Felipe, et al.
The Lancet Regional Health. Europe|November 30, 2023
Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysisAnika Kästner, Anna Kron, Neeltje van den Berg, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Ebiomedicine|February 6, 2023
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseasesAlexander M Bernhardt, Steffen Tiedt, Daniel Teupser, et al.
Virchows Archiv : an International Journal of Pathology|November 25, 2019
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading schemeRiuko Ohashi, Guido Martignoni, Arndt Hartmann, et al.
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
Pageof 51